Physician's Weekly

JUNE 25, 2025

I’m the Vice Chairman of Rheumatology at the Cleveland Clinic and the co-director of the Center for Vasculitis Care and Research. And I’m here today to talk about giant cell arteritis in clinical practice. Hello everyone. I’m Paras Karmacharya. And RINVOQ is the first oral JAK inhibitor approved for GCA.

Management 59

Management Diagnosis Patient-Centered Patients 59

PEMBlog

OCTOBER 2, 2024

I’ll dive into the latest clinical practice guidelines and discuss evidence-based approaches to diagnosis and treatment. Understanding dyspepsia and its clinical presentation. Join me as I scope out the nuances of gastroesophageal reflux and gastritis and provide practical insights for clinicians in the emergency setting.

Diagnosis 52

Diagnosis Management IT Patient-Centered 52

GeriPal

JUNE 12, 2025

So in my practice, I typically recommend multi fraction or higher dose regimens for patients who have extra osseous extension or complicated bone Metastases, which, you know, most of the data surrounding equivalency of pain relief is in this sort of uncomplicated bone metastasis population. There may be co pays or things like that.

Patient-Centered 102

Patient-Centered Referral Patients IT 102

GeriPal

MARCH 9, 2023

FDA is considering approval, shifting away from Schedule I restrictions, paving the way for use in clinical practice. Alex: It’s complicated. We, for very complicated reasons, ended up with niacin. Legalization is moving forward in several states , following the lead of Oregon and Colorado. Eric: Yeah.

Patient-Centered 91

Patient-Centered Community IT Medical 91

GeriPal

JUNE 6, 2024

Don 13:50 Well, you know, I think one of the issues, though, when you ask about prevalence data, especially, say, in the oncology world, not only does it matter about how you ask the questions, but because it’s such a complicated topic, people may infer very different things as to what you’re talking about. Sharon 15:21 Right.

Illness 130

Illness IT Physicals Patients 130